Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Uamuzi wa Urefu wa Mfereji wa Mizizi× | Uchambuzi wa Biomarkers za Mate× | |
|---|---|---|
| Nyanja | Tiba ya Meno | Tiba ya Meno |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 1920s (radiography); 1960s (electronic) | 2000s+ (clinical application) |
| Mwanzilishi≠ | Multiple innovators (radiographic and electronic methods) | Multiple innovators (Giannobile, Malamud, et al.) |
| Aina≠ | Diagnostic and measurement procedure | Laboratory and point-of-care diagnostics |
| Chanzo asilia≠ | Ingle, J. I., Bakland, L. K., & Baumgartner, J. C. (2008). Endodontics (6th ed.). BC Decker. link ↗ | Giannobile, W. V., McDevitt, J. T., Niedbala, R. S., Malamud, D., & Prozorovsky, T. (2009). Translating molecular diagnostics into clinical practice: Designing the next generation of oral health technologies. Advances in Dental Research, 23(1), 80-89. link ↗ |
| Majina mbadala≠ | working length measurement, WL determination, electronic apical locator, periapical radiography | saliva testing, salivary diagnostics, oral biomarker assessment |
| Zinazohusiana | 3 | 3 |
| Muhtasari≠ | Root canal length determination (working length) is a critical procedural step in endodontic therapy that establishes the precise depth to which instrumentation, irrigation, and obturation should extend within the root canal system. Modern approaches combine electronic apical locators (EAL) with radiographic verification to accurately locate the apical foramen and establish the working length. Accurate working length determination is essential for successful endodontic treatment, preventing under-instrumentation (leaving infected material) and over-instrumentation (causing periapical inflammation). | Salivary biomarker analysis detects protein, molecular, or microbial markers in saliva that indicate oral and systemic disease. Salivary diagnostics assess risk and activity of dental caries, periodontal disease, oral cancer, and other conditions. Biomarkers include antimicrobial proteins (lysozyme, lactoferrin), inflammatory mediators (interleukins, TNF-alpha), cariogenic bacteria (Streptococcus mutans), and virulence factors. Point-of-care saliva testing offers rapid, non-invasive alternatives to conventional laboratory methods, enabling chairside diagnosis and personalized risk assessment. |
| ScholarGateSeti ya data ↗ |
|
|